Capricor Therapeutics Financial Ratios Analysis

Valuation, profitability, leverage, and liquidity ratios

Scroll to see more
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Valuation Ratios
P/S Ratio28.185.9838.19288.92226.06
P/B Ratio4.316.668.272.262.49
Price/Tangible Book4.316.668.272.262.49
Price/FCF62.58
Price/OCF19.82
Enterprise Value Ratios
EV/Revenue24.434.9421.01122.30113.31
EV/FCF34.43
Profitability & Returns
Return on Equity (ROE)-0.48%-1.30%-1.34%-0.67%-0.78%
Return on Assets (ROA)-0.23%-0.28%-0.41%-0.34%-0.37%
Return on Capital Employed (ROCE)-0.28%-0.88%-1.12%-0.56%-0.43%
Leverage & Solvency Ratios
Debt/Equity0.010.100.220.090.01
Debt/FCF1.64
Liquidity Ratios
Current Ratio7.771.631.828.8111.33
Quick Ratio7.701.591.788.5411.01
Efficiency Ratios
Asset Turnover0.190.460.060.010.01
Yield & Distribution Ratios
Earnings Yield-0.06%-0.15%-0.30%-0.28%-0.19%
FCF Yield-0.07%-0.18%0.02%-0.25%-0.15%
Buyback Yield-0.32%-0.09%-0.06%-0.48%-3.20%